ArticleBiotechnology for biofuels and bioproducts2024
Biochemical and inhibitor analysis of recombinant cellobiohydrolases from Phanerochaete chrysosporium.
Article in Biotechnology for biofuels and bioproducts, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The demand for greener energy sources necessitates the development of more efficient processes. Lignocellulosic biomass holds significant potential for biofuels production, but improvements in its enzymatic degradation are required to mitigate the susceptibility of enzymes by reaction products and pretreatment impurities. In this work, two cellobiohydrolases (CBHs) from the basidiomycete Phanerochaete chrysosporium (PcCel7C and PcCel7D) were heterologously expressed, characterized, and analyzed in the presence of their products (glucose and cellobiose) and harmful compounds commonly found in industrial processes (phenolics), as well as their adsorption to lignin and cellulose. The enzymes exhibited an optimum temperature of 55 °C and displayed a pH profile similar to the model CBHI from Trichoderma reesei (TrCel7A). Activity decreased consistently for all CBHs in the presence of cellobiose, while glucose significantly impacted the basidiomycete CBHs. Phenolic compounds with a higher content of OH groups were found to be more detrimental to the enzymes, with the location of the OH group on the phenolic ring playing a crucial role in enzyme deactivation. Molecular docking simulations predicted that the product-binding site of CBHs has the highest affinity for interaction with phenolics; however, they are unlikely to interact at this site in the presence of substrate. PcCel7C and PcCel7D exhibited poorer adsorption on cellulose compared to the TrCel7A enzyme. These findings provide insights into how the structure of CBHs influences their susceptibility to inhibitors and deactivating compounds present in saccharification reaction medium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.